Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent
1995-06-05
1997-10-07
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
514 29, 514152, 514163, 514184, 514192, 514198, 514199, 514200, 514390, 514398, 514503, 514927, A61K 3165, A61K 3170, A61K 3161, A61K 31555
Patent
active
056748582
ABSTRACT:
The use is described of both (i) ranitidine bismuth citrate and (ii) one or more Helicobacter pylori-inhibiting antibiotics in treating or preventing gastrointestinal disorders.
Pharmaceutical compositions containing both (i) and (ii) and methods for the preparation of pharmaceutical compositions containing (i) and (ii) are also described.
REFERENCES:
patent: 5008256 (1991-04-01), Clitherow
patent: 5128140 (1992-07-01), Chapura et al.
patent: 5196205 (1993-03-01), Borody
patent: 5256684 (1993-10-01), Marshall
Journal of Antimicrobial Chemotherapy (1988) 22, 631-636.
Glaxo Group Limited
Henley III Raymond
LandOfFree
Medicaments for treating gastrointestinal disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicaments for treating gastrointestinal disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments for treating gastrointestinal disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2357502